Výsledky vyhledávání - Scappaticci, Frank
- Zobrazuji výsledky 1 - 4 z 4
-
1
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review Autor Rugo, Hope S., Jacobs, Ira, Sharma, Shikhar, Scappaticci, Frank, Paul, Thomas A., Jensen-Pergakes, Kristen, Malouf, Gabriel G.
Vydáno 2020Text -
2
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Autor Parikh, Aparna R., Lee, Fa-Chyi, Yau, Linda, Koh, Han, Knost, James, Mitchell, Edith P., Bosanac, Ivan, Choong, Nicholas, Scappaticci, Frank, Mancao, Christoph, Lenz, Heinz-Josef
Vydáno 2019Text -
3
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM) Autor Hurwitz, Herbert I., Tan, Benjamin R., Reeves, James A., Xiong, Henry, Somer, Brad, Lenz, Heinz‐Josef, Hochster, Howard S., Scappaticci, Frank, Palma, John F., Price, Richard, Lee, John J., Nicholas, Alan, Sommer, Nicolas, Bendell, Johanna
Vydáno 2018Text -
4
Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Renal Cell Cancer (RCC) after Sunitinib Failure Autor Tannir, Nizar M., Wong, Yu-Ning, Kollmannsberger, Christian K., Ernstoff, Marc S., Perry, David J., Appleman, Leonard J., Posadas, Edwin M., Cho, Daniel, Choueiri, Toni K., Coates, Andrew, Gupta, Neeraj, Pradhan, Rajendra, Qian, Jiang, Chen, Jihong, Scappaticci, Frank A., Ricker, Justin L., Carlson, Dawn M., Michaelson, M. Dror
Vydáno 2011Text